GLIS3
Zinc finger protein GLIS3
Also known as: GLIS3_HUMAN, MGC33662, ZNF515
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NEA6
- Gene
- GLIS3
- Ensembl
- ENSG00000107249
- Chromosome
- 9
- Canonical length
- 775 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Golgi apparatus,Primary cilium
OverviewNCBI Gene
This gene is a member of the GLI-similar zinc finger protein family and encodes a nuclear protein with five C2H2-type zinc finger domains. This protein functions as both a repressor and activator of transcription and is specifically involved in the development of pancreatic beta cells, the thyroid, eye, liver and kidney. Mutations in this gene have been associated with neonatal diabetes and congenital hypothyroidism (NDH). Alternatively spliced variants that encode different protein isoforms have been described but the full-length nature of only two have been determined. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
775 residues, UniProt reviewed canonical sequence.
>Q8NEA6|GLIS3
1 MMVQRLGLIS PPASQVSTAC NQISPSLQRA MNAANLNIPP SDTRSLISRE SLASTTLSLT
61 ESQSASSMKQ EWSQGYRALP SLSNHGSQNG LDLGDLLSLP PGTSMSSNSV SNSLPSYLFG
121 TESSHSPYPS PRHSSTRSHS ARSKKRALSL SPLSDGIGID FNTIIRTSPT SLVAYINGSR
181 ASPANLSPQP EVYGHFLGVR GSCIPQPRPV PGSQKGVLVA PGGLALPAYG EDGALEHERM
241 QQLEHGGLQP GLVNHMVVQH GLPGPDSQSA GLFKTERLEE FPGSTVDLPP APPLPPLPPP
301 PGPPPPYHAH AHLHHPELGP HAQQLALPQA TLDDDGEMDG IGGKHCCRWI DCSALYDQQE
361 ELVRHIEKVH IDQRKGEDFT CFWAGCPRRY KPFNARYKLL IHMRVHSGEK PNKCTFEGCE
421 KAFSRLENLK IHLRSHTGEK PYLCQHPGCQ KAFSNSSDRA KHQRTHLDTK PYACQIPGCT
481 KRYTDPSSLR KHVKAHSSKE QQARKKLRSS TELHPDLLTD CLTVQSLQPA TSPRDAAAEG
541 TVGRSPGPGP DLYSAPIFSS NYSSRSGTAA GAVPPPHPVS HPSPGHNVQG SPHNPSSQLP
601 PLTAVDAGAE RFAPSAPSPH HISPRRVPAP SSILQRTQPP YTQQPSGSHL KSYQPETNSS
661 FQPNGIHVHG FYGQLQKFCP PHYPDSQRIV PPVSSCSVVP SFEDCLVPTS MGQASFDVFH
721 RAFSTHSGIT VYDLPSSSSS LFGESLRSGA EDATFLQIST VDRCPSQLSS VYTEGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GLIS3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.64
- Highest tissue expression
- 14 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 14 nTPM
- pancreas: 8.8 nTPM
- fallopian tube: 7.6 nTPM
- choroid plexus: 6.7 nTPM
- seminal vesicle: 6.2 nTPM
- cervix: 5.3 nTPM
Single-cell type
- renal connecting tubule cells: 1,923 nCPM
- choroid plexus epithelial cells: 1,624 nCPM
- ependymal cells: 1,553 nCPM
- pancreatic duct cells: 1,414 nCPM
- renal collecting duct principal cells: 1,210 nCPM
- astrocytes: 1,075 nCPM
Immune cell
- basophil: 0.2 nTPM
- naive CD8 T-cell: 0.1 nTPM
- neutrophil: 0.1 nTPM
- non-classical monocyte: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- medulla oblongata: 49 nTPM
- choroid plexus: 44 nTPM
- midbrain: 40 nTPM
- spinal cord: 32 nTPM
- white matter: 30 nTPM
- hypothalamus: 26 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GLIS3.
Disease | AllUniProt
Conditions GLIS3 is implicated in, by any mechanism.
- Diabetes mellitus, neonatal, with congenital hypothyroidism (NDH) MIM:610199
Disease | GeneticClinVar
17 pathogenic / likely-pathogenic of 794 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Neonatal diabetes mellitus with congenital hypothyroidism
- GLIS3-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.74
- gnomAD pLI
- 0
- gnomAD missense Z
- -3.14
- DepMap mean gene effect
- 0.12
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of transcription by RNA polymerase II
- positive regulation of transcription by RNA polymerase II
- regulation of transcription by RNA polymerase II
- transcription by RNA polymerase II
Molecular functions
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GLIS3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GLIS3 as an antibody target. Whether an autoantibody or antibody against GLIS3 could matter depends on whether native GLIS3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GLIS3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GLIS3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...